Becton Dickinson and Co at UBS Genomics 2.0 and Medtech Innovations Summit (Virtual) Transcript
Great. Good afternoon, everyone. Welcome to our next session here in the MedTech Innovations Virtual Summit. I'm Matt Taylor, UBS' U.S. medical supplies and devices analyst and really pleased to be joined by management from Becton, Dickinson.
We're calling this session Fueling Innovation Since 1897, which is not something that we could say for, I think, any other company that we cover, so a long history here.
And we're very pleased to be joined today by Tom Polen, who's the President and CEO of BD; and also, we have Patrick Kaltenbach, who's the EVP and President of the Life Sciences segment.
So we'll have a robust fireside discussion with the group here focusing in and out on overall Becton innovations but also specifically on some in life sciences. And it's a great opportunity to get a kind of drill down on that segment as well.
So Tom and Patrick, thank you so much for joining us today. And thanks for spending the time.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
